Current Recommendations for Pneumococcal Vaccination of Children and Adults

نویسندگان

  • Hossein Fakhraei
  • Soheila Khalilzadeh
  • Ghamartaj Khanbabaei
  • Susan Mahmoudi
  • Mohammad Reza Masjedi
  • Mahshid Mehdizadeh
  • Abbas Momenzadeh
  • Alireza Nateghian
  • Payam Tabarsi
  • Parviz Tabatabaei
  • Davoud Yadegarinia
چکیده

Hossein Fakhraei , Soheila Khalilzadeh 2 , Ghamartaj Khanbabaei , Susan Mahmoudi, Mohammad Reza Masjedi , Mahshid Mehdizadeh , Abbas Momenzadeh, Alireza Nateghian , Payam Tabarsi , Parviz Tabatabaei , Davoud Yadegarinia 9 1 National Immunization Committee of Ministry of health, Tehran, Iran, 2 Clinical TB and Epidemiology Research Center, Masih Daneshvari Hospital, NRITLD, Shahid Beheshti University of Medicine Sciences, Tehran, Iran, 3 Mofid Hospital, Shahid Beheshti University of Medicine Sciences, Tehran, Iran, 4 Department of Communicable Disease Prevention, Ministry of health, Tehran ,Iran, 5 Shahid Beheshti University of Medicine Sciences, Tehran , Iran, 6 Children Medical Center Hospital, Tehran University of Medicine Sciences, Tehran, Iran, 7 Aliasghar Hospital, Iran University of Medicines Sciences, Tehran , Iran, 8 Iranian Pediatrics Infectious Society, Tehran, Iran, 9 Labafinezhad Hospital, Shahid Beheshti University of Medicine Sciences, Tehran , Iran

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Recommendations for Pneumococcal Immunization Outside Routine Childhood Immunization Programs in Western Europe

The global burden of pneumococcal diseases is high, with young children and adults≥50 years of age at highest risk of infection. Two types of vaccine are available for the prevention of pneumococcal diseases caused by specific Streptococcus pneumoniae serotypes: the pneumococcal polysaccharide vaccine (PPV23) and the pneumococcal conjugate vaccine (PCV7, PCV10, and PCV13). Despite pneumococcal ...

متن کامل

Pneumococcal Disease Prevention Among Adults: Strategies for the Use of Pneumococcal Vaccines.

Use of the pneumococcal conjugate vaccines among children in the U.S. since 2000 has dramatically reduced pneumococcal disease burden among adults. Significant vaccine-preventable morbidity and mortality from pneumococcal infections still remains, especially among older adults. The U.S. Advisory Committee on Immunization Practices (ACIP) has recently recommended the routine use of both pneumoco...

متن کامل

Immunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus

Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease which is characterized by B-cell abnormality and auto-antibody generation. Since bacterial infections are the most important causes of mortality in these patients, pneumococcal vaccination is recommended for children with SLE. Objective: To investigate humoral immunity and specific-antibody formation in response to a...

متن کامل

1097Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States

Background. Recently published efficacy data for 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPV23) provides an opportunity to update cost-effectiveness analyses of the current ACIP recommendations as well as potential extensions of the ACIP recommendations. Methods. We applied an economic model in a US cohort of 50-year old adults to eval...

متن کامل

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany

This study describes the effects of the introduction of universal infant pneumococcal conjugate vaccination in 2006 on invasive pneumococcal disease (IPD) among children and adults in Germany with a focus on the dynamics of serotype distribution in vaccinated and non-vaccinated age groups. Over a period of 22 years (1992-2014), microbiological diagnostic laboratories from all over Germany have ...

متن کامل

Pneumococcal vaccines for children and adults with bronchiectasis.

BACKGROUND Bronchiectasis is increasingly recognized as a major cause of respiratory morbidity especially in developing countries. Even in affluent countries, bronchiectasis is increasingly seen in some community subsections (e.g. Aboriginal communities) and occurs as a comorbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease (COPD). Respiratory exa...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 14  شماره 

صفحات  -

تاریخ انتشار 2015